Matzuk M M, Kumar T R, Shou W, Coerver K A, Lau A L, Behringer R R, Finegold M J
Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.
Recent Prog Horm Res. 1996;51:123-54; discussion 155-7.
With the advent of gene targeting in pluripotent mouse embryonic stem cells, it is now possible to modify the mammalian genome to generate mutant strains of mice with precise genetic mutations. The major goal of my laboratory is to generate transgenic mice to use as physiologic models to study mammalian reproduction and development. The initial focus of our research has been to generate mice deficient in inhibins, activins, activin binding proteins (i.e., follistatin), and activin receptors (i.e., activin receptor type II) to understand their interactions and roles in the hypothalamic-pituitary-gonadal axis and mammalian development. Inhibins and activins, dimeric members of the TGF-beta superfamily, were discovered due to their role in pituitary follicle stimulating hormone homeostasis. However, these proteins have later been shown to have diverse endocrine, paracrine, and autocrine functions. Activins have been shown to mediate their signals through type I and type II serine/threonine kinase receptors. The high interspecies conservation of activins, inhibins, and activin receptors and the universal presence of activins in mammals, birds, amphibians, and fish suggest an evolutionarily conserved role of these proteins in animal development. Our initial studies have demonstrated a tumor suppressor role of inhibin in the gonads and adrenals and have also suggested a role of activins in cancer cachexia-like syndrome. To further study the gonadal tumor development and the cancer cachexia-like syndrome in these mice, we have begun to generate mice with multiple genetic alterations (e.g., mice deficient in both inhibin and Mullerian inhibiting substance). We have also generated mice deficient in other components of this complex system (e.g., activin beta A, activin receptor type II, follistatin). Analysis of these transgenic mutant models has aided our overall understanding of the critical roles these proteins play in the development of the reproductive system, in the modulation of the endocrine milieu that regulates reproductive function, and in mammalian development.
随着多能小鼠胚胎干细胞基因靶向技术的出现,现在有可能对哺乳动物基因组进行修饰,以产生具有精确基因突变的小鼠突变品系。我实验室的主要目标是培育转基因小鼠,用作生理模型来研究哺乳动物的生殖与发育。我们研究的最初重点是培育缺乏抑制素、激活素、激活素结合蛋白(即卵泡抑素)和激活素受体(即Ⅱ型激活素受体)的小鼠,以了解它们在下丘脑-垂体-性腺轴及哺乳动物发育中的相互作用和作用。抑制素和激活素是转化生长因子-β超家族的二聚体成员,因其在垂体促卵泡激素稳态中的作用而被发现。然而,后来发现这些蛋白质具有多种内分泌、旁分泌和自分泌功能。已证明激活素通过Ⅰ型和Ⅱ型丝氨酸/苏氨酸激酶受体介导其信号。激活素、抑制素和激活素受体在物种间具有高度保守性,且在哺乳动物、鸟类、两栖动物和鱼类中普遍存在,这表明这些蛋白质在动物发育中具有进化上保守的作用。我们的初步研究已证明抑制素在性腺和肾上腺中具有肿瘤抑制作用,也提示激活素在癌症恶病质样综合征中起作用。为了进一步研究这些小鼠的性腺肿瘤发生和癌症恶病质样综合征,我们已开始培育具有多种基因改变的小鼠(例如,同时缺乏抑制素和苗勒管抑制物质的小鼠)。我们还培育了缺乏该复杂系统其他成分(例如,激活素βA、Ⅱ型激活素受体、卵泡抑素)的小鼠。对这些转基因突变模型的分析有助于我们全面了解这些蛋白质在生殖系统发育、调节生殖功能的内分泌环境调节以及哺乳动物发育中所起的关键作用。